Pioneering the next generation of immunotherapy
A breakthrough in chronic disease treatment, making biologic therapies accessible to underserved patients and advancing global healthcare affordability.
Redefining what therapeutic vaccines can achieve
We are developing the next generation of therapeutic vaccines, designed to surpass conventional biologics by enabling patients to generate natural antibodies against harmful targets.
Our mission is to expand access to high-quality, cost-effective treatments for chronic diseases, reaching underserved patient populations who cannot access traditional biologic therapies, like mAbs. By driving innovation, we aim to make affordable healthcare a global reality.
